GLP-1 analogue-loaded glucose-responsive nanoparticles as allies of Stem Cell therapies for the treatment of type I diabetes
[1] [2] Compounded semaglutide and tirzepatide are not FDA-approved as finished drug products, so talk to a licensed provider about what fits your situation
This may increase side effects, particularly nausea and reduced appetite
Gier B, Matveyenko AV, Kirakossian D, et al
This stability is important for preventing complications of diabetes, such as nerve damage, kidney disease, and eye problems
Researchers studying the broader axis often combine IGF-1 LR3 work with separate studies using GH secretagogues like CJC-1295/Ipamorelin or Tesamorelin to drive endogenous GH and IGF-1 production, then compare results